Personal Injury Law Blog
Key takeaways:
The legal claims against Novo Nordisk are not about banning the drug. They are about accountability and informed consent. The core of these lawsuits is the product liability principle known as “failure to warn.”
Pharmaceutical companies have a legal duty to inform the medical community and the public about the known risks of their products. This information allows doctors and patients to make educated decisions about their healthcare.
Plaintiffs in the Ozempic and Wegovy lawsuits argue that the manufacturer knew, or should have known, about the potential for severe stomach paralysis but did not reflect this danger on the warning label.
Many medications have mild, temporary side effects. The warning labels for these drugs did mention nausea and vomiting.
However, the lawsuits contend that the manufacturer’s warnings did not prepare anyone for the severity, permanence, and debilitating nature of conditions like gastroparesis, a condition that is a complete and often irreversible shutdown of stomach function.
As individuals nationwide filed lawsuits with similar allegations, the federal court system recognized the need for a more efficient process. This led to the creation of multidistrict litigation, or MDL.
In February 2024, a judicial panel issued a transfer order to consolidate all federal Ozempic and Wegovy lawsuits into a single proceeding. This MDL, assigned to the Eastern District of Pennsylvania in Philadelphia, streamlines pretrial activities.
An MDL is not a class-action lawsuit; each plaintiff’s case remains individual.
Managing these complex cases requires a structured approach. The MDL process helps coordinate evidence gathering and legal rulings, which is beneficial for plaintiffs with similar claims.
The selection of Philadelphia as the venue for this MDL is significant for people in the region. With Stark & Stark’s offices in both Pennsylvania and New Jersey, our personal injury attorneys are positioned to represent local clients in this national litigation. It allows for direct participation in a legal process happening right in our community.
The primary injury alleged in these lawsuits is gastroparesis, a medical term for stomach paralysis. This condition is devastating and can require lifelong medical management. It occurs when the stomach muscles no longer function to move food into the small intestine.
For those affected, gastroparesis means living with constant nausea, frequent and violent vomiting of undigested food, severe abdominal pain, and significant weight loss.
Patients may require feeding tubes to get necessary nutrition. The condition profoundly impacts a person’s ability to work, socialize, and lead a normal life.
If you believe you have been harmed by one of these medications, taking organized steps can help protect your health and your legal rights.
Your immediate focus should be on your medical care and documenting your experience.
This information provides the factual foundation an attorney needs to evaluate your potential claim and advise you on the next steps.
Ozempic and Wegovy belong to a class of drugs called GLP-1 receptor agonists. They work in part by slowing down digestion, which helps control blood sugar and makes a person feel full longer. The lawsuits allege that this slowing effect goes too far in some people, leading to a near-complete shutdown of stomach motility.
Now that the MDL is established, the litigation enters a critical phase of evidence gathering and legal arguments. The process will take time, but it is a necessary step toward uncovering the facts.
The court will establish a schedule for attorneys to exchange documents and take testimony from company employees, medical experts, and the plaintiffs themselves.
The current MDL primarily includes lawsuits related to Ozempic, Wegovy, and Rybelsus, all of which are manufactured by Novo Nordisk. Other similar drugs, like Mounjaro, may be subjects of separate or future litigation.
The reason for your prescription does not affect your eligibility to file a claim. The core issue is whether you took the drug and subsequently developed a severe, improperly warned-of condition like gastroparesis, regardless of the initial diagnosis.
Your attorney will work with medical experts to establish a causal link. This involves a thorough review of your medical records to show a clear timeline between starting the medication and the onset of severe gastrointestinal symptoms, while also working to rule out other potential causes.
Each state has a statute of limitations, which is a deadline for filing a product liability claim. Because the knowledge of this potential link is relatively new, it is crucial to speak with an attorney as soon as possible to protect your right to file.
If you or a loved one took Ozempic or Wegovy and suffered from stomach paralysis or other severe intestinal problems, you deserve answers.
Stark & Stark’s mass tort attorneys are actively investigating these claims and can help you understand your legal options. Contact us at 800.535.3425 or fill out our online form for a free and confidential case evaluation.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...
